GrayBug Names BD Head

Gerald D. Cagle Ph.D., has been appointed senior advisor and head of business development at GrayBug LLC. “GrayBug is at the forefront of innovative drug delivery strategies for ocular diseases and has the potential to significantly advance the ophthalmic industry with its unique sustained release technology,” said Dr. Cagle. “I am very excited to be joining the Graybug team and look forward to being involved in the progression of their novel drug delivery technology to market.” Dr. Cagle has more than 35 years of managerial, technical and business experience in the pharmaceutical industry. He formerly served as senior vice president and chief scientific officer at Alcon Laboratories, and held other key leadership roles including lab scientist, followed by service in clinical research, regulatory affairs, and product development.